# Belén Gari-jo Faces Pressure to Revitalize Sanofi's Pipeline

https://www.expansion.com/economia/financial-times/2026/10/30/podra-belen-garijo-revitalizar-cartera-productos-desarrollo-sanofi.html

Belén Garijo faces pressure to develop new successful drugs for Sanofi to replace Dupixent revenue. Sanofi's product pipeline is under review. Dupixent remains a key revenue source.

Image: https://e00-expansion.uecdn.es/assets/multimedia/imagenes/2026/10/30/17933744345459.jpg

Image: https://e00-expansion.uecdn.es/assets/multimedia/imagenes/2026/10/30/17933744345459_150x0.jpg

#sanofi #pharmaceuticals #dupixent

---

Canonical URL: https://qwibbit.com/q36017

Created: 2026-10-30T16:00:42.405797+00:00

Last edited: 2026-10-30T16:00:42.405797+00:00

Board: 3

Origin: Syndicated

Original source: https://www.expansion.com/economia/financial-times/2026/10/30/podra-belen-garijo-revitalizar-cartera-productos-desarrollo-sanofi.html